Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hansen Medical, Inc. (HNSN): Hedge Funds Are Snapping Up

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow over 700 of the best-performing investors and by analyzing their 13F filings, we can determine the stocks that they are collectively bullish on. One of their picks is Hansen Medical, Inc. (NASDAQ:HNSN), so let’s take a closer look at the sentiment that surrounds it in the current quarter.

Hansen Medical, Inc. (NASDAQ:HNSN)’s stock took a couple of terrible hits this year and lost over 55% in August alone. Due to its small size, the company is not very popular among the funds we track, but it still registered an increase in sentiment during the third quarter.  However, the level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Perceptron, Inc. (NASDAQ:PRCP), Northern Technologies International Corp (NASDAQ:NTIC), and Inuvo, Inc. (NYSEMKT:INUV) to gather more data points.

Follow Hansen Medical Inc (NASDAQ:HNSN)
Trade (NASDAQ:HNSN) Now!

In the eyes of most shareholders, hedge funds are seen as underperforming, outdated financial tools of the past. While there are greater than 8000 funds in operation today, Our researchers look at the masters of this group, about 700 funds. These hedge fund managers shepherd most of the smart money’s total capital, and by following their top stock picks, Insider Monkey has come up with a few investment strategies that have historically outperformed the market. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, we’re going to analyze the new action surrounding Hansen Medical, Inc. (NASDAQ:HNSN).

What have hedge funds been doing with Hansen Medical, Inc. (NASDAQ:HNSN)?

Heading into Q4, a total of 4 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 33% from the second quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Matthew Strobeck’s Birchview Capital has the largest position in Hansen Medical, Inc. (NASDAQ:HNSN), worth close to $14.3 million, corresponding to 8.5% of its total 13F portfolio. Coming in second is Ryan Heslop and Ariel Warszawski’s Firefly Value Partners, with a $0.7 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Remaining professional money managers that hold long positions consist of Jim Tarantino and Chris Galvin’s Westerly Capital Management, Adam Usdan’s Trellus Management Company.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.